Baumal Caroline (CIK 1961100) reported 14 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-05-14). Recent activity: Sell APLS (86,525 shares), Buy APLS (41,250 shares), Sell APLS (41,250 shares), Buy APLS (26,396 shares), Sell APLS (26,396 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Medical Officer | Sell | 86,525 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Medical Officer | Buy | 41,250 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Medical Officer | Sell | 41,250 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Medical Officer | Buy | 26,396 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Medical Officer | Sell | 26,396 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Medical Officer | Sell | 8,888 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Medical Officer | Sell | 12,723 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Medical Officer | Sell | 29,696 | $0 |
| 2026-05-01 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Medical Officer | Sell | 900 | $0 |
| 2026-01-23 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Medical Officer | Sell | 2,797 | $60,891 |
| 2026-01-21 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Medical Officer | Sell | 1,882 | $37,245 |
| 2026-01-06 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Medical Officer | Sell | 3,020 | $77,101 |
| 2025-01-21 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Medical Officer | Sell | 1,853 | $55,516 |
| 2025-01-21 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Medical Officer | Buy | 39,594 | $0 |
Source: SEC Form 4 filings · as of 2026-05-14